233 related articles for article (PubMed ID: 37621949)
1. Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis.
Pei D
ACS Symp Ser Am Chem Soc; 2022; 1417():179-197. PubMed ID: 37621949
[TBL] [Abstract][Full Text] [Related]
2. Designing Cell-Permeable Macrocyclic Peptides.
Appiah Kubi G; Dougherty PG; Pei D
Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
[TBL] [Abstract][Full Text] [Related]
3. Targeting intracellular protein-protein interactions with macrocyclic peptides.
Buyanova M; Pei D
Trends Pharmacol Sci; 2022 Mar; 43(3):234-248. PubMed ID: 34911657
[TBL] [Abstract][Full Text] [Related]
4. Understanding Cell Penetration of Cyclic Peptides.
Dougherty PG; Sahni A; Pei D
Chem Rev; 2019 Sep; 119(17):10241-10287. PubMed ID: 31083977
[TBL] [Abstract][Full Text] [Related]
5. Development of a Cyclic, Cell Penetrating Peptide Compatible with In Vitro Selection Strategies.
Abrigo NA; Dods KK; Makovsky CA; Lohan S; Mitra K; Newcomb KM; Le A; Hartman MCT
ACS Chem Biol; 2023 Apr; 18(4):746-755. PubMed ID: 36920103
[TBL] [Abstract][Full Text] [Related]
6. Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction.
Salim H; Song J; Sahni A; Pei D
J Org Chem; 2020 Feb; 85(3):1416-1424. PubMed ID: 31609620
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles.
Cleal K; He L; Watson PD; Jones AT
Curr Pharm Des; 2013; 19(16):2878-94. PubMed ID: 23140451
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Cellular Uptake, Endosomal Escape, and Cytosolic Entry Efficiencies of Cyclic Peptides.
Salim H; Pei D
Methods Mol Biol; 2022; 2371():301-316. PubMed ID: 34596855
[TBL] [Abstract][Full Text] [Related]
9. Targeting intracellular protein-protein interactions with cell-permeable cyclic peptides.
Qian Z; Dougherty PG; Pei D
Curr Opin Chem Biol; 2017 Jun; 38():80-86. PubMed ID: 28388463
[TBL] [Abstract][Full Text] [Related]
10. Stapled Peptides Inhibitors: A New Window for Target Drug Discovery.
Ali AM; Atmaj J; Van Oosterwijk N; Groves MR; Dömling A
Comput Struct Biotechnol J; 2019; 17():263-281. PubMed ID: 30867891
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide.
Dougherty PG; Wen J; Pan X; Koley A; Ren JG; Sahni A; Basu R; Salim H; Appiah Kubi G; Qian Z; Pei D
J Med Chem; 2019 Nov; 62(22):10098-10107. PubMed ID: 31657556
[TBL] [Abstract][Full Text] [Related]
13. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
14. Development of Hydrophobic Cell-Penetrating Stapled Peptides as Drug Carriers.
Tsuchiya K; Horikoshi K; Fujita M; Hirano M; Miyamoto M; Yokoo H; Demizu Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511527
[TBL] [Abstract][Full Text] [Related]
15. Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif.
Wen J; Liao H; Stachowski K; Hempfling JP; Qian Z; Yuan C; Foster MP; Pei D
Bioorg Med Chem; 2020 Oct; 28(20):115711. PubMed ID: 33069067
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides.
Qian Z; Martyna A; Hard RL; Wang J; Appiah-Kubi G; Coss C; Phelps MA; Rossman JS; Pei D
Biochemistry; 2016 May; 55(18):2601-12. PubMed ID: 27089101
[TBL] [Abstract][Full Text] [Related]
17. Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.
González-Muñiz R; Bonache MÁ; Pérez de Vega MJ
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467010
[TBL] [Abstract][Full Text] [Related]
18. Cell-Penetrating Peptides Predicted From CASC3, AKIP1, and AHRR Proteins.
Porosk L; Põhako K; Arukuusk P; Langel Ü
Front Pharmacol; 2021; 12():716226. PubMed ID: 34504427
[TBL] [Abstract][Full Text] [Related]
19. Cyclic Peptides for Protein-Protein Interaction Targets: Applications to Human Disease.
Rubin S; Qvit N
Crit Rev Eukaryot Gene Expr; 2016; 26(3):199-221. PubMed ID: 27650985
[TBL] [Abstract][Full Text] [Related]
20. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant A; Cardon S; Burlina F; Sagan S
Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
